Working throughout the fiercely competitive sectors of immuno-oncology and biotechnology, Agenus differentiates by itself through a deep dedication to scientific innovation and specialized excellence. The corporation’s method displays a calculated equilibrium between groundbreaking investigation and methodical clinical analysis, Hence developing

With a strong scientific-phase pipeline, Agenus harnesses a mix of proprietary antibody platforms, for instance Retrocyte Display™ and SECANT®, and innovative cell therapy methods, positioning itself being a essential contributor during the biotechnology and immunotherapy arena.A segment of text or a graphical merchandise that serves like a cros